Royalty Pharma PLC
RPRX37.615USD
+0.505+1.36%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
16.01BMarket Cap
14.65P/E TTM
Royalty Pharma PLC
37.615
+0.505+1.36%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
Total revenue
0.05%568.25M
-0.41%593.64M
5.29%564.69M
-0.17%537.27M
-16.96%567.98M
5.36%596.07M
-6.48%536.31M
0.42%538.20M
21.69%683.97M
-1.73%565.75M
-2.10%573.46M
-3.43%535.96M
-1.92%562.05M
0.62%575.70M
8.80%585.77M
8.62%554.96M
14.40%573.03M
25.06%572.14M
15.97%538.40M
11.65%510.93M
15.18%500.88M
--457.49M
--464.28M
--457.61M
--434.88M
Operating expenses
-94.69%34.06M
1479.41%232.13M
-144.27%-170.38M
-7.51%267.64M
213.05%641.75M
-103.89%-16.83M
0.95%384.87M
82.95%289.36M
-40.12%205.00M
2.44%432.58M
34.85%381.25M
183.25%158.16M
-0.41%342.33M
229.82%422.28M
915.81%282.72M
-287.02%-189.99M
146.49%343.73M
114.64%128.03M
140.80%27.83M
-21.71%101.59M
3401.10%139.45M
---874.43M
---68.22M
--129.75M
--3.98M
R&D expenses
10000.00%50.50M
0.00%500.00K
-99.01%500.00K
0.00%500.00K
0.00%500.00K
-99.01%500.00K
98.04%50.50M
-17.49%500.00K
-99.50%500.00K
-51.36%50.50M
-71.82%25.50M
-80.59%606.00K
3705.38%100.50M
1234.63%103.82M
1675.90%90.50M
-45.95%3.12M
-65.43%2.64M
-50.98%7.78M
-77.57%5.10M
-73.08%5.78M
-66.77%7.64M
--15.87M
--22.72M
--21.46M
--22.99M
Depreciation, depletion, and amortization
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
0.00%5.80M
0.00%5.80M
0.00%5.73M
-13.12%5.73M
--5.80M
--5.80M
--5.73M
--6.60M
Other operating expenses
-121.79%-127.14M
314.39%164.04M
-182.13%-227.60M
-11.94%212.43M
391.23%583.60M
-124.77%-76.51M
-9.15%277.14M
128.19%241.23M
-35.65%118.80M
15.89%308.85M
121.32%305.06M
143.37%105.71M
-36.83%184.62M
314.21%266.50M
507.90%137.84M
-615.59%-243.76M
232.07%292.26M
107.00%64.34M
72.38%-33.79M
-34.53%47.28M
275.91%88.01M
---919.16M
---122.34M
--72.21M
---50.03M
Operating profit
824.08%534.18M
-41.02%361.51M
385.38%735.07M
8.35%269.63M
-115.40%-73.77M
360.23%612.90M
-21.21%151.44M
-34.13%248.84M
117.99%478.97M
-13.20%133.17M
-36.58%192.21M
-49.29%377.79M
-4.18%219.72M
-65.46%153.42M
-40.64%303.05M
81.99%744.95M
-36.56%229.30M
-66.66%444.11M
-4.12%510.57M
24.85%409.35M
-16.12%361.43M
--1.33B
--532.50M
--327.86M
--430.90M
Net non-operating interest income (expenses)
Non-operating interest income
52.22%11.29M
39.03%9.04M
-25.29%17.51M
-47.84%13.38M
-55.59%7.42M
-85.18%6.50M
66.99%23.44M
134.94%25.65M
75.28%16.70M
312.19%43.85M
14.46%14.03M
-22.21%10.92M
-42.59%9.53M
-49.84%10.64M
672.59%12.26M
415.31%14.04M
480.76%16.60M
553.22%21.21M
-65.36%1.59M
-39.11%2.72M
-71.50%2.86M
--3.25M
--4.58M
--4.47M
--10.03M
Non-operating interest expense
47.54%65.26M
39.16%65.76M
44.47%66.51M
4.40%49.01M
-5.79%44.23M
0.64%47.26M
-2.01%46.03M
-0.04%46.95M
-0.24%46.95M
-0.04%46.95M
5.98%46.98M
25.49%46.97M
25.79%47.06M
24.13%46.97M
40.97%44.33M
9.47%37.43M
-30.18%37.41M
-40.26%37.84M
-54.29%31.44M
-50.57%34.19M
-20.34%53.58M
--63.34M
--68.80M
--69.17M
--67.27M
Gains from sale of securities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
Return on equity
145.54%6.44M
11709.70%31.65M
299.29%10.41M
321.17%1.70M
-140.89%-14.15M
103.91%268.00K
-60.63%-5.22M
-204.48%-770.00K
8616.88%34.61M
81.97%-6.86M
-218.26%-3.25M
-95.84%737.00K
120.70%397.00K
-462.18%-38.02M
-80.00%2.75M
-39.57%17.70M
78.86%-1.92M
197.19%10.50M
270.89%13.74M
459.68%29.29M
-64.12%-9.07M
---10.80M
---8.04M
---8.14M
---5.53M
Special income (expenses)
-140.40%-50.16M
-99.94%100.00K
69172.67%111.53M
-138.33%-47.32M
334.52%124.15M
122.33%163.49M
-99.79%161.00K
-17.77%123.47M
154.17%28.57M
-3459.14%-732.08M
247.02%75.20M
122.11%150.15M
-10.74%-52.74M
71.79%-20.57M
-139.95%-51.15M
-65.25%67.60M
74.48%-47.63M
-139.34%-72.92M
726.23%128.04M
355.26%194.54M
-768.76%-186.61M
--185.37M
---20.45M
---76.21M
--27.90M
Other non-operating income (expenses)
16.91%-3.06M
88.04%-2.19M
3.10%-1.65M
449.95%6.00M
-31.00%-3.69M
-1471.50%-18.31M
84.19%-1.71M
205.41%1.09M
-60.10%-2.81M
75.83%-1.17M
-1261.66%-10.80M
-867.29%-1.03M
-4186.05%-1.76M
-405.26%-4.82M
-144.98%-793.00K
-141.00%-107.00K
100.73%43.00K
1027.86%1.58M
659.91%1.76M
805.41%261.00K
-10312.07%-5.92M
--140.00K
--232.00K
---37.00K
--58.00K
Income before tax
10243.53%433.43M
-53.41%334.35M
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-1236.61%-610.03M
-0.62%220.41M
-39.06%491.60M
-19.43%128.08M
-85.36%53.67M
-64.47%221.80M
34.02%806.75M
45.72%158.98M
-74.65%366.63M
41.87%624.25M
236.73%601.98M
-72.46%109.10M
--1.45B
--440.03M
--178.77M
--396.09M
Income tax
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
10243.53%433.43M
-53.41%334.35M
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-1236.61%-610.03M
-0.62%220.41M
-39.06%491.60M
-19.43%128.08M
-85.36%53.67M
-64.47%221.80M
34.02%806.75M
45.72%158.98M
-74.65%366.63M
41.87%624.25M
236.73%601.98M
-72.46%109.10M
--1.45B
--440.03M
--178.77M
--396.09M
Net income from continuous operations
10243.53%433.43M
-53.41%334.35M
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-1236.61%-610.03M
-0.62%220.41M
-39.06%491.60M
-19.43%128.08M
-85.36%53.67M
-64.47%221.80M
34.02%806.75M
45.72%158.98M
-74.65%366.63M
41.87%624.25M
236.73%601.98M
-72.46%109.10M
--1.45B
--440.03M
--178.77M
--396.09M
Net Income attributable to non-controlling interests
2255.39%195.08M
-43.50%126.14M
425.13%262.37M
-25.33%92.37M
-105.38%-9.05M
245.02%223.25M
-35.75%49.96M
-33.88%123.71M
120.56%168.33M
-436.37%-153.95M
-35.13%77.76M
-48.88%187.09M
-15.07%76.32M
-76.59%45.77M
-64.07%119.87M
128.88%365.98M
137.37%89.86M
648.26%195.53M
974.64%333.62M
490.98%159.90M
32.13%37.86M
--26.13M
--31.05M
--27.06M
--28.65M
Net income attributable to controlling interests
4888.47%238.35M
-57.88%208.21M
654.34%543.99M
-55.19%102.00M
-98.60%4.78M
208.39%494.34M
-49.45%72.11M
-25.25%227.63M
558.32%340.75M
-5870.29%-456.08M
39.95%142.65M
-30.92%304.50M
-25.11%51.76M
-95.38%7.90M
-64.93%101.93M
1216.85%440.78M
-2.98%69.12M
-87.95%171.09M
-28.94%290.63M
-77.94%33.47M
-80.61%71.24M
--1.42B
--408.98M
--151.71M
--367.44M
Net income attributable to common shareholders
4888.47%238.35M
-57.88%208.21M
654.34%543.99M
-55.19%102.00M
-98.60%4.78M
208.39%494.34M
-49.45%72.11M
-25.25%227.63M
558.32%340.75M
-5870.29%-456.08M
39.95%142.65M
-30.92%304.50M
-25.11%51.76M
-95.38%7.90M
-64.93%101.93M
1216.85%440.78M
-2.98%69.12M
-87.95%171.09M
-28.94%290.63M
-77.94%33.47M
-80.61%71.24M
--1.42B
--408.98M
--151.71M
--367.44M
Basic earnings per share
5039.15%0.55
-57.84%0.47
655.72%1.22
-55.25%0.23
-98.61%0.01
207.49%1.11
-50.48%0.16
-27.58%0.51
541.09%0.76
-5729.59%-1.03
36.43%0.32
-35.19%0.70
-32.74%0.12
-95.73%0.02
-69.70%0.24
1038.74%1.08
48.22%0.18
-82.00%0.43
14.35%0.79
-62.89%0.09
-80.61%0.12
--2.39
--0.69
--0.25
--0.62
Diluted earnings per share
5056.76%0.55
-57.83%0.47
658.65%1.21
-55.20%0.23
-98.62%0.01
207.39%1.11
-50.70%0.16
-27.70%0.50
540.66%0.76
-5729.59%-1.03
36.33%0.32
-35.19%0.70
-32.74%0.12
-95.73%0.02
-69.70%0.24
1038.65%1.08
48.21%0.18
-82.01%0.43
14.35%0.79
-62.89%0.09
-80.61%0.12
--2.39
--0.69
--0.25
--0.62
Dividend per share
-100.00%0.00
10.00%0.22
110.00%0.42
5.00%0.21
--0.21
-48.72%0.20
5.26%0.20
5.26%0.20
--0.00
8.33%0.39
11.76%0.19
11.76%0.19
--0.00
12.50%0.36
13.33%0.17
--0.17
--0.00
--0.32
--0.15
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
